JUMPCODE GENOMICS

San Diego, CA

Oncologygene editingGrant-only

What changed

Study registered, no phase assigned: A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

3w agoTrial registeredJun 22, 2026Source filing (opens the source filing in a new tab)

Momentum

72no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R43 · $384k · non-dilutive
Mar 3, 2025
JUMPCODE GENOMICS · PI BROWN, KEITH · NHGRI · award ends Feb 28, 2027 · CRISPR-based depletion method for resolving pseudogene contamination in Next Generation Sequencing (NGS) based genetic testing
NIH RePORTER · NIH RePORTER 11066297 (opens the source filing in a new tab)
Grant
R21 · $248k · non-dilutive
Feb 1, 2025
WEILL MEDICAL COLL OF CORNELL UNIV · PI OTTERBURN, DAVID · NCI · award ends Jan 31, 2027 · Characterizing the autologous fat graft microenvironment resulting from differential intraoperative processing techniques: A comparative analysis and its clinical implications
NIH RePORTER · NIH RePORTER 11034931 (opens the source filing in a new tab)
Trial
NA registered
May 19, 2021
Mastectomy, Mammaplasty, Breast Reconstruction · RECRUITING · sponsor: Weill Medical College of Cornell University · A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
ClinicalTrials.gov · NCT04891510 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the trial record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
new_entity links the grant record at 0.22{"reasons":["no candidate cleared the review threshold"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
3w agoTrial recruitingSource (opens the source filing in a new tab)
NIH R43 · $0.4M · CRISPR-based depletion method for resolving pseudogene contamination in Next Generation Sequencing (NGS) based genetic testing
Feb 2025New grantSource (opens the source filing in a new tab)
NIH R21 · $0.2M · Characterizing the autologous fat graft microenvironment resulting from differential intraoperative processing techniques: A comparative analysis and its clinical implications
Jan 2025New grantSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R43 · $384k · non-dilutive

R21 · $248k · non-dilutive

NA registered